文献速递基础与转化研究流行病学与生物统计组学、生物样本库与精准医学

遗传增强的DXA-BMD预测模型在不同种族和地理人群中性能的变异性:一项风险预测研究

Variability in performance of genetic-enhanced DXA-BMD prediction models across diverse ethnic and geographic populations: A risk prediction study.
PubMed 文献 · PLoS Med · 2024-08-30

研究利用英国生物银行17964名英国白人个体开发股骨颈和腰椎骨密度预测模型,并在5个英国生物银行测试集和12个不同 ancestry 独立队列(总计超过15000人)中测试。模型在European white人群中预测的骨密度与脆性骨折风险显著相关,但在其他种族和独立队列中性能下降。

要点

  • 在SNP纳入阈值为5×10-6和5×10-7时,股骨颈和腰椎骨密度预测模型的最高R²分别为27.70%和48.28%。
  • 加入遗传因素较仅用临床因素略微改善预测,股骨颈和腰椎骨密度分别额外解释2.3%和3%的变异。
  • 预测的股骨颈和腰椎骨密度与European white人群脆性骨折风险显著相关(P < 0.001),但在其他种族和独立队列中模型性能下降。

核心结论

  • 结合遗传和临床因素较仅用临床因素改善骨密度预测。
  • 调整遗传变异纳入阈值(如5×10-6或5×10-7)而非仅考虑GWAS显著变异可增强模型解释力。
  • 研究强调需要在多样化人群中训练模型以提高不同种族和地理群体的预测性能。

研究设计与样本

  • 使用英国生物银行17964名英国白人个体开发股骨颈和腰椎骨密度预测模型,采用LASSO回归,基于5973名英国白人模型选择子集的判定系数(R²)选择模型。
  • 模型在5个英国生物银行测试集和12个不同 ancestry 独立队列(总计超过15000人)中测试。
  • 在英国生物银行287183名无DXA-BMD的European white参与者病例对照集中评估预测骨密度与10年脆性骨折风险的相关性。

主要发现

  • 在SNP纳入阈值为5×10-6和5×10-7时,股骨颈和腰椎骨密度预测模型的最高R²分别为27.70%(95%CI [27.56%, 27.84%])和48.28%(95%CI [48.23%, 48.34%])。
  • 加入遗传因素较仅用临床因素额外解释股骨颈骨密度2.3%和腰椎骨密度3%的变异。
  • 预测的股骨颈骨密度和腰椎骨密度与European white人群脆性骨折风险显著相关(P < 0.001),HR分别为0.83(95%CI [0.79, 0.88],对应10年绝对风险差异1.44%)和0.72(95%CI [0.68, 0.76],对应10年绝对风险差异1.64%),即骨密度每增加一个标准差,骨折风险分别降低17%和28%。
  • 模型在其他种族和独立队列中性能下降。

局限性

  • 临床因素分布存在差异。
  • 仅使用SNP作为遗传因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone mineral density (BMD) and diagnosing osteoporosis, but its costliness and complexity impede widespread screening adoption. Predictive modeling using genetic and clinical data offers a cost-effective alternative for assessing osteoporosis and fracture risk. This study aims to develop BMD prediction models using data from the UK Biobank (UKBB) and test their performance across different ethnic and geographical populations. METHODS AND FINDINGS: We developed BMD prediction models for the femoral neck (FNK) and lumbar spine (SPN) using both genetic variants and clinical factors (such as sex, age, height, and weight), within 17,964 British white individuals from UKBB. Models based on regression with least absolute shrinkage and selection operator (LASSO), selected based on the coefficient of determination (R2) from a model selection subset of 5,973 individuals from British white population. These models were tested on 5 UKBB test sets and 12 independent cohorts of diverse ancestries, totaling over 15,000 individuals. Furthermore, we assessed the correlation of predicted BMDs with fragility fractures risk in 10 years in a case-control set of 287,183 European white participants without DXA-BMDs in the UKBB. With single-nucleotide polymorphism (SNP) inclusion thresholds at 5×10-6 and 5×10-7, the prediction models for FNK-BMD and SPN-BMD achieved the highest R2 of 27.70% with a 95% confidence interval (CI) of [27.56%, 27.84%] and 48.28% (95% CI [48.23%, 48.34%]), respectively. Adding genetic factors improved predictions slightly, explaining an additional 2.3% variation for FNK-BMD and 3% for SPN-BMD over clinical factors alone. Survival analysis revealed that the predicted FNK-BMD and SPN-BMD were significantly associated with fragility fracture risk in the European white population (P < 0.001). The hazard ratios (HRs) of the predicted FNK-BMD and SPN-BMD were 0.83 (95% CI [0.79, 0.88], corresponding to a 1.44% difference in 10-year absolute risk) and 0.72 (95% CI [0.68, 0.76], corresponding to a 1.64% difference in 10-year absolute risk), respectively, indicating that for every increase of one standard deviation in BMD, the fracture risk will decrease by 17% and 28%, respectively. However, the model's performance declined in other ethnic groups and independent cohorts. The limitations of this study include differences in clinical factors distribution and the use of only SNPs as genetic factors. CONCLUSIONS: In this study, we observed that combining genetic and clinical factors improves BMD prediction compared to clinical factors alone. Adjusting inclusion thresholds for genetic variants (e.g., 5×10-6 or 5×10-7) rather than solely considering genome-wide association study (GWAS)-significant variants can enhance the model's explanatory power. The study highlights the need for training models on diverse populations to improve predictive performance across various ethnic and geographical groups.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Liu Y, Meng XH, Wu C, et al. Variability in performance of genetic-enhanced DXA-BMD prediction models across diverse ethnic and geographic populations: A risk prediction study. PLoS Med. 2024. PMID: 39213443. doi:10.1371/journal.pmed.1004451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。